<PAGE>
Exhibit 23.2
Once the exchange of stock described in note 1 to the accompanying
consolidated financial statements has been consummated, we will be in a
position to render the following consent:
"CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the use in this Registration Statement on Form S-1 of
our reports dated March 29, 2000 relating to the consolidated financial
statements and financial statement schedules of Charles River Laboratories
International, Inc., which appear in such Registration Statement.
We also consent to the references to us under the headings "Experts" in such
Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
June 6, 2000"
